AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer
S. Sardar, C. M. McNair, L. Ravindranath, S. N. Chand, W. Yuan, D. Bogdan, J. Welti, A. Sharp, N. K. Ryan, M. J. Schiewer, E. G. DeArment, T. Janas, X. A. Su, L. M. Butler, J. S. de Bono, , A. A. Shafi
This study identifies CBP/p300 as critical for DNA repair in prostate cancer and shows that targeting it enhances therapeutic response.
bioRxiv · May 7, 2024Cancer Biology